Charles River Laboratories International, Inc.
$379.15
+5.17 · +1.38% today
Market open · updated 12:45:29 PM ET
- High
- $377.76 10:40 AM
- Low
- $357.00 9:20 AM
Against the S&P 500 Price change through Oct 28, 2026
CRL+87.48%
S&P 500+13.26%
CRL+99.00%
S&P 500+12.41%
CRL+116.69%
S&P 500+88.06%
CRL−14.77%
S&P 500+68.51%
Key numbers
- Previous close
- $373.98
- Open
- $375.00
- Day's range
- $370.54 – $379.49
- 52-week range
- $146.20 – $379.49
- Volume
- 311,618
- Average volume
- 980,213
- Market value
- $18.3 billion
- Earnings per share
- -$4.92last 12 months
- Beta
- 1.40moves about 1.4× as much as the market
- Dividend
- None
- 50-day average
- $298.83
- 200-day average
- $220.28
Wednesday, Nov 4, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Charles River Laboratories International competes with From our value chain
Charles River Laboratories International in the news
- HeadlineCharles River Laboratories (CRL) Earnings Expected to Grow: Should You Buy?Zacks Investment Research · October 28, 2026 at 11:01 AM ET
- HeadlineCharles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential AssessmentBusiness Wire · October 22, 2026 at 4:30 PM ET
- Market closeS&P 500, Dow and Nasdaq Close Higher as Tech Leads Wednesday RallyWiseView Research desk · October 21, 2026
- CongressJefferson Shreve sold $15,001 - $50,000 of CRLHouse filing · disclosed Jun 23, 2025
- CongressJefferson Shreve bought $15,001 - $50,000 of CRLHouse filing · disclosed Jun 23, 2025
- CongressRob Bresnahan sold $1,001 - $15,000 of CRLHouse filing · disclosed Jun 2, 2025
- CongressRob Bresnahan bought $15,001 - $50,000 of CRLHouse filing · disclosed May 8, 2025
- CongressJulie Johnson bought $1,001 - $15,000 of CRLHouse filing · disclosed Feb 13, 2025
Earnings
Next report: Wednesday, Nov 4, 2026, before the open.
Congress trades in CRL
4 purchases and 2 sales in the latest 6 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Jefferson ShreveHouse · R-Indiana | Sale | $15,001 - $50,000 | May 12, 2025 | Jun 23, 2025 |
| Jefferson ShreveHouse · R-Indiana | Purchase | $15,001 - $50,000 | May 8, 2025 | Jun 23, 2025 |
| Rob BresnahanHouse | Sale | $1,001 - $15,000 | May 15, 2025 | Jun 2, 2025 |
| Rob BresnahanHouse | Purchase | $15,001 - $50,000 | Apr 8, 2025 | May 8, 2025 |
| Julie JohnsonHouse · D-Texas | Purchase | $1,001 - $15,000 | Jan 15, 2025 | Feb 13, 2025 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Nov 15, 2024 | Dec 6, 2024 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Charles River Laboratories International
Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 19,000
- Headquarters
- Wilmington, Massachusetts
- Website
- criver.com
- Listed
- Jun 23, 2000
More medical - diagnostics & research stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.